Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Muscular dystrophies.

Brenda L Wong

    Pediatric Annals
    |August 12, 2005
    PubMed
    Summary

    Technological advances are broadening the definition of muscular dystrophy (MD) and improving care. While a cure is not yet available, aggressive supportive treatment by an integrated health team enhances patient quality and length of life.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The burden of bone disease in Duchenne muscular dystrophy: age-specific prevalence of osteoporosis and low bone density.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
    Same author

    Appendicular lean mass index and motor function in ambulatory patients with Duchenne muscular dystrophy.

    Muscle & nerve·2024
    Same author

    The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy.

    Neurology and therapy·2024
    Same author

    Moving Beyond the 2018 Minimum International Care Considerations for Osteoporosis Management in Duchenne Muscular Dystrophy (DMD): Meeting Report from the 3rd International Muscle-Bone Interactions Meeting 7th and 14th November 2022.

    Journal of neuromuscular diseases·2023
    Same author

    Appendicular lean mass index changes in patients with Duchenne muscular dystrophy and Becker muscular dystrophy.

    Journal of cachexia, sarcopenia and muscle·2023
    Same author

    Disease progression rates in ambulatory Duchenne muscular dystrophy by steroid type, patient age and functional status.

    Journal of comparative effectiveness research·2023

    Area of Science:

    • Neurology
    • Genetics
    • Biomedical Engineering

    Background:

    • Muscular Dystrophy (MD) is a group of inherited genetic disorders characterized by progressive muscle weakness and degeneration.
    • Recent technological advancements are expanding the understanding and definition of MD.
    • Gene therapy offers a promising future prospect for a definitive cure.

    Discussion:

    • The current standard of care emphasizes aggressive supportive treatment for patients with MD.
    • An integrated healthcare team approach is crucial for managing the complexities of MD.
    • Improving the quality of life for individuals with MD is a primary objective.

    Key Insights:

    • Technological progress has redefined the scope of Muscular Dystrophy.
    • Improved medical care is enhancing patient outcomes.
    • Gene therapy represents a significant future therapeutic avenue.

    Outlook:

    • Continued research in gene therapy holds the potential for curing MD.
    • Enhanced supportive care strategies will further improve patient longevity and well-being.
    • Interdisciplinary collaboration is essential for advancing MD patient management.

    Related Experiment Videos